U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07859293) titled 'An Extension Trial of Asedebart in Participants With Congenital Adrenal Hyperplasia' on Sept. 29.
Brief Summary: The main goal of the trial is to study the long-term safety, how well people can handle the treatment, and how asedebart acts in the body and affects the body when used to treat classic congenital adrenal hyperplasia (CAH). The trial will include participants who have previously received asedebart in trial 19873A (NCT05669950).
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Adrenal Hyperplasia, Congenital
Intervention:
DRUG: Asedebart
Solution for injection/infusion
Recruitment Status: NOT_YET_RECR...